Autism Spectrum Disorder Trial, Recruiting (NCT06362733)

Autism Spectrum Disorder Trial, Recruiting NCT06362733 Sponsor: Stanford University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06362733 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child's parent or guardian must be 18 years or older, and the child must be between 4 and 17 years old at the time of enrollment.
The child has been diagnosed with autism spectrum disorder (ASD), or there is a strong suspicion of ASD that is confirmed through a standardized assessment called the ADI-R.
The child's parent or guardian has reported significant concerns about the child needing things to stay the same and having difficulty with flexibility in behavior.
The child has been on a stable treatment plan — including any medications and behavioral therapies — for at least two weeks, with no changes expected during the study.
Both the parent or guardian and the child are able to communicate and participate in study activities in English.
The family lives in the United States.

Who may not be able to join:

No specific exclusion criteria were listed in the official trial description (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antonio Hardan, MD, Stanford University

Phone: 650-736-1235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06362733

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 650-736-1235

More information: https://clinicaltrials.gov/study/NCT06362733

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child's parent or guardian must be 18 years or older, and the child must be between 4 and 17 years old at the time of enrollment.
The child has been diagnosed with autism spectrum disorder (ASD), or there is a strong suspicion of ASD that is confirmed through a standardized assessment called the ADI-R.
The child's parent or guardian has reported significant concerns about the child needing things to stay the same and having difficulty with flexibility in behavior.
The child has been on a stable treatment plan — including any medications and behavioral therapies — for at least two weeks, with no changes expected during the study.
Both the parent or guardian and the child are able to communicate and participate in study activities in English.
The family lives in the United States.

Who may not be able to join:

No specific exclusion criteria were listed in the official trial description (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

11 July 2024

Est. completion

1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from Baseline in Insistence on Sameness Subscale of the Dimensional Assessment of Restricted and Repetitive Behaviors (DARB).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov